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RESUMEN
Los medidores de glucosa se utilizan para ayudar al 
profesional de la salud a monitorear y detectar alteraciones 
de la glucosa sanguínea (GS). El objetivo fue comparar la téc-
nica de HemoCue (HC) versus glucosa oxidasa (GOx) para la 
medición de GS utilizando 368 mediciones de GS por ambos 
métodos. Se utilizaron gráficos de Bland & Altman, prueba 
de t-pareada y regresión lineal para su comparación. Se en-
contró concordancia entre los métodos en la mayoría de los 
niveles de glucosa, excepto a concentraciones de glucosa ≥ 
6.993 mmol / L. El analizador de glucosa HC es bueno para 
su uso en estudios de campo ya que es técnicamente fácil 
y requiere muy poco mantenimiento; sin embargo, se reco-
mienda tener especial cuidado con aquellas personas cuyos 
valores de glucosa están dentro del límite del diagnóstico de 
diabetes ya que, con el método HC, existe el riesgo de cla-
sificar erróneamente a las personas que ya tienen diabetes 
como no diabéticas. Por lo tanto, dada la importancia de 
conocer los valores reales de los niveles de glucosa en este 
grupo de personas para un diagnóstico preciso, se recomien-
da considerar un análisis posterior con el método GOx para 
corroborar el resultado.
Palabras clave: Glucosa sanguínea, HemoCue, Glucosa Oxi-
dasa.
ABSTRACT
To monitor and detect blood glucose (BG) abnorma-
lities, health professionals use glucose meters. The study’s 
objective was to compare HemoCue (HC) versus glucose 
oxidase (GOx) for the measurement of BG using 368 mea-
surements of BG by both methods. Bland & Altman graphs, 
paired t-test and linear regression were used to compare the 
methods. Concordance was found between the methods 
in most glucose levels, except at glucose concentrations ≥ 
6.993 mmol / L. HC glucose analyzer is good for use in field 
studies because it is technically easy and requires very little 
maintenance; however, it is recommended to take special 
care with people whose glucose values are within the limit of 
the diagnosis of diabetes, since with the HC method there is 
a risk of misclassifying people who already have diabetes, as 
non-diabetics. Therefore, given the importance of knowing 
the actual values of glucose levels in this group of people 
for an accurate diagnosis, considering a subsequent analysis 
with the GOx method to corroborate the result is recommen-
ded.
Key words: Blood glucose, HemoCue, Glucose Oxidase.
INTRODUCTION
Type 2 diabetes is considered a major global public 
health problem, so it is important to study its prevalence in 
order to generate policies aimed at the prevention and con-
trol of the disease. To achieve this objective, it is necessary 
to have diagnostic and monitoring tools that allow accurate 
results obtained reliably and quickly, which has become 
the main objective of various studies (Reach y Wilson, 1992; 
Turner et al., 1999; Wang, 2001; Tonyushkina y Nichol, 2009; 
Clarke y Foster, 2012).
There are many blood glucose meters or glucose 
analyzers that are widely used in hospitals, emergency rooms, 
outpatient medical care, and at home for self-monitoring. 
Blood glucose meters are designed to measure glucose in 
either whole blood (capillary or venous), serum, or plasma, 
providing a quick analysis of blood glucose levels. They are 
useful for clinicians for consultation or in field work as well as 
for patients with diabetes, allowing them to test themselves 
and help better manage their blood glucose (Tonyushkina y 
Nichol, 2009; Clarke y Foster, 2012).
The HemoCue (HC) is a portable, fast, simple and re-
liable system for the determination of total blood glucose by 
the glucose dehydrogenase modified method. It uses inte-
grated quality control and is very safe, requires little volume 
of whole blood, and is an instrument accepted by the Clinical 
Laboratory of Thomas Jefferson University Hospital (Torjman 
et al., 2001). Beyond obtaining the results in a very short time 
(from 40 to 240 “ depending on the glucose concentration in 
the sample), the results are also comparable to glucose con-
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centrations obtained using traditional laboratory methods. 
Capillary or venous blood, as well as whole arterial blood, 
can be used for glucose analysis by the HC method, making it 
possible to use in laboratory or field work (Meyer et al., 1998; 
2001; Marley et al., 2007; Tonyushkina y Nichol, 2009; Torjman 
et al., Reddy et al., 2014).
In fieldwork, especially in remote areas, it is difficult 
to immediately analyze the blood samples obtained, since 
often there are not adequate facilities or appropriate tools to 
do so in the visited communities. Tools such as the HemoCue 
(HC), which measures glucose concentration shortly after the 
sample has been obtained, can be very useful. The objective 
of this work was to compare the HemoCue technique against 
the GOx method for blood glucose measurement using data 
from a cross sectional study of diabetes in Comcáac (Seri) 
adults of Punta Chueca and El Desemboque, Sonora.
MATERIALS AND METHODS
All Comcáac residents of Punta Chueca and El Des-
emboque, Sonora who were 20 years of age or older were 
invited to participate in a cross sectional survey through a 
face-to-face home interview conducted by trained person-
nel and the health promoter of each community. Informed 
consent was obtained from subjects before participation 
in the protocol approved by the ethics committee of the 
Centro de Investigacion en Alimentacion y Desarrollo, A.C. 
in Hermosillo, Sonora, Mexico (number CE/005/2013). More 
details regarding the protocol can be found elsewhere (Ro-
bles-Ordaz et al., 2018).
Approximately 7 mL of blood were taken from each 
participant, which was placed in a gray cap tube (with potas-
sium oxalate and sodium fluoride as anticoagulant from the 
BD Vacutainer ™ system, Code 367925). To avoid glycolysis, 
once the blood samples were obtained they were kept on 
ice, until centrifugation at 3400 rpm for 15 min (Thermo 
Scientific Centrifuge, Sorval ST 40R, Germany) to obtain the 
plasma. The resulting plasma was poured in vials for storage 
in freezing (-20 °C) until transported to the city of Hermosillo 
to be stored at -70 °C at the biochemical laboratory of the 
Diabetes Research Unit of the Centro de Investigacion en 
Alimentacion y Desarrollo, A.C., where analysis was carried 
out as recommended (Sacks et al., 2011; Urquidez-Romero et 
al., 2014; ADA, 2015).
During field work, previous to sample centrifugation 
and after gently homogenizing each blood sample with anti-
coagulant, a drop of whole blood was taken for glucose anal-
ysis by the HemoCue β-glucose system (Hemocue Glucose 
201+) (field method) (Sacks et al., 2011; Urquidez-Romero et 
al., 2014).
An oral glucose tolerance test was performed after a 
10 – 12 h fasting period, using a 75 g glucose load (Dextrosol, 
catalogue number 5375; Hycel) according to the World Health 
Organization recommendations. Plasma glucose levels was 
determined before and after the 2-h post load condition by 
the GOx method (Randox GOD/PAP®) (traditional method).
The HC has internal quality control: its analyzer au-
tomatically checks the performance of its optical drive. In 
addition, it has two external controls of the HC System, low 
level and high level, with mean values manufacturer-labeled 
as 4.662 mmol / L (3.6075 – 5.7165 mmol / L), and 18.5925 
mmol / L (16.0395 – 21.1455 mmol / L), respectively, which 
were evaluated during the field work at least once daily. In 
addition, the HC reading microcuvettes were handled and 
stored according to the recommendations of the manufac-
turing company (Eurotrol Glocotrol®-AQ (Ref 180.013.002, 
Eurotrol B.V., Keperlaan 20, 6716 BS Ede, The Netherlands). 
In the present study, a single measurement per collected 
sample was performed, with repeated measurements done 
only to corroborate in cases where there was doubt about 
the result obtained by HemoCue.
Plasma glucose (GOx technique) was determined by 
duplicate at CIAD laboratory. Using a colorimetric method 
based in a GOx reaction (GOD/PAP Randox®), serum controls 
were run (serum control level 2, catalog number: CAL2350A 
and serum control level 3, catalog number: HE2613, Randox) 
to assure quality control. All samples were read in a semi-au-
tomatic clinical chemistry analyzer RX Monza.
A total of 736 of blood glucose measurements were 
obtained from this study. 368 were obtained using the HC 
technique (field method) and 368 using the GOx (traditional 
method). Data were divided into five groups: group 1, all 
glucose measurements no matter the glucose level; group 
2, glucose measurements less than 5.55 mmol / L; group 3, 
glucose measurements less than 6.993 mmol / L; group 4, 
glucose measurements greater than or equal to 5.55 mmol / 
L; and group 5, glucose measurements greater than or equal 
to 6.993 mmol / L.
Statistical analysis
Results were compared using Bland and Altman plots. 
The mean difference between HC and GOx measurements 
was considered as the dependent variable and the average 
of the measurements as the independent variable. The 
magnitude of overestimation was evaluated when the mean 
value of the differences between the method (bias or measu-
rement error) was above the zero line (zero line considered as 
the perfect agreement between methods); or underestimate, 
when the mean value of differences was below the zero line. 
In each case, over or underestimation of HC methods were 
considered significant regarding GOx when the p-value 
obtained by the paired t-test comparing the mean value of 
the differences between methods was less than or equal to 
0.05 (comparing differences in mean glucose of the HC aga-
inst the GOx method). If the p-value of this test was higher 
than 0.05, there was no significant difference between the 
two methods, i.e., the means of the differences were equal 
to zero. The concordance limits were also estimated in the 
Bland and Altman plots as reported (Bland y Altman, 1986).
Simple linear regression was used to assess whether 
differences in glucose values between the two methods 
exhibited a lack of homogeneity of differences across the 
averages between methods. Whether differences in glucose 
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values exhibited trends of under or overestimation of the HC 
method was determined based on the beta parameter (ne-
gative or positive value, respectively) and its corresponding 
p-value. A trend of under or overestimation was considered 
when beta was negative or positive with corresponding p-
value ≤ 0.05. Otherwise, when the p value was > 0.05, the 
differences were considered to be homogeneous along the 
average values of the glucose concentrations measured by 
the two methods.
The percentage of errors or residuals falling outside 
the Bland and Altman concordance interval was also estima-
ted by counting the individual values and their percentage 
expression in relation to the total population analyzed per 
group. All analysis was performed using STATA version 14.1 
statistical software program (Stata Corp LP, College Station, 
Texas, U.S.A.).
RESULTS
Means (± SD) of the glucose measurements by the HC 
and GOx methods of all groups defined by glucose levels are 
shown in Table 1. In Group 1, the mean of glucose measured 
by the HC was 6.639 ± 2.283 mmol / L and 6.637 ± 2.387 mmol 
/ L by the GOx. In Group 2, the mean of glucose measured by 
the HC was 4.86 ± 0.471 mmol / L and 4.866 ± 0.432 mmol 
/ L by the GOx. Similarly, in Group 3, the mean of glucose 
measured by the HC was 5.486 ± 0.699 mmol / L and that 
of GOx was 5.443 ± 0.688 mmol / L. In Group 4, the mean of 
glucose measured by the HC was 7.897 ± 2.459 mmol / L and 
that by GOx was 7.952 ± 2.586 mmol / L. In Group 5, the mean 
of glucose measured by HC was 10.021 ± 2.592 mmol / L and 
10.193 ± 2.723 mmol / L by the GOx.
The concordance or agreement between the HC 
and GOx methods for each studied group was evaluated by 
Bland and Altman plots, paired t-tests, and linear regression 
analyses. In this graph, the concordance of the method of 
interest (in our case, the HC) against the method used as a 
reference (the GOx) was evalauted by comparing the average 
of the mean difference line, against the zero line (average dif-
ferences equal to zero). The zero line is defined in the graph 
as the line of perfect agreement, considering a complete 
concordance or agreement when both lines are transposed 
(Rebel et al., 2012).
Figure 1 shows the Bland and Altman plot of the 
difference in glucose measurements between the compared 
methods against its averages for Group 1. The mean of glu-
cose differences between methods was 0.02 mmol / L, which 
was not significantly different from zero (p = 0.9555). This 
result indicates a concordance between the methods when 
all glucose measurements are included in the analysis (Group 
1). However, the regression line indicates (β = - 0.0045, p = 
0.0046) that the mean of glucose differences between 
methods (y line) did not have a homogeneous or consistent 
distribution over the range of glucose averages; in other 
words, as the average of glucose between methods increases 
(x line), the glucose levels measured by the HC were lower 
than those measured by the GOx. The limits of agreement 
were - 1.398 (- 2SD) to 1.402 (2SD) with 5.71 % of differences 
or errors outside the limits of concordance.
Table 1. Mean glucose levels measured by the HemoCue and GOx 
methods organized by groups of glucose concentrations. 
Tabla 1. Valores de media de los niveles de glucosa medidos por los mé-






Group 1 (n=368) 6.639 ± 2.283 6.637 ± 2.387
Group 2 (n=95) 4.86 ± 0.471 4.866 ± 0.432
Group 3 (n=248) 5.486 ± 0.699 5.443 ± 0.688
Group 4 (n=197) 7.897 ± 2.459 7.952 ± 2.586
Group 5 (n=80) 10.021 ± 2.592 10.193 ± 2.723
*Data presented as mean ± standard deviation. Group 1 (all glucose 
measurements); Group 2 (glucose measurements < 5.55 mmol / L); 
Group 3 (glucose measurements < 6.993 mmol / L); Group 4 (glucose 





Figure 2 shows the Bland and Altman plot of the dif-
ference in glucose measurements between methods against 
its averages for Group 2. The mean of glucose differences 
between methods for this group was - 0.006 mmol / L; similar 
to that of Group 1, the mean in Group 2 was also very close to 
zero (p = 0.8684). Furthermore, the regression line indicated 
that mean differences had a homogeneous distribution (β = 
0.1064, p = 0.2636) over the range of glucose averages used 
Figure 1. Mean difference for glucose measurements between HemoCue 
and Glucose oxidase method (reference method) versus their glucose 
average (mmol / L), for all glucose values. 
Figura 1. Diferencia de media vs promedio de glucosa (mmol / L) para los 
valores de glucosa entre los métodos HemoCue y glucosa oxidasa (método 
de referencia) para todos los valores de glucosa juntos.
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in Group 2 (glucose measurements < 5.55 mmol / L) or normal 
glucose level. The limits of agreement were - 0.761 (- 2SD) to 
0.748 (2SD) with 5.26 % of differences or errors outside the 
limits of concordance.
For Group 3 (Figure 3) the Bland and Altman plot 
shows a good concordance between the compared meth-
ods, as the mean glucose difference was near zero (0.0432, 
p = 0.2303). Furthermore, the mean glucose differences were 
homogeneously distributed (β = 0.02, p = 0.7248) over the 
glucose concentrations that defined Group 3 (glucose levels 
lower than 6.993 mmol / L). The limits of agreement were 
- 1.088 (- 2SD) to 1.174 (2SD) with 5.24 % of differences or 
errors outside the limits of agreement.
Figure 4 shows the Bland and Altman plot of the 
difference in glucose measurements between the compared 
methods against its averages for Group 4. Similar to Group 
1, a good concordance between the methods was shown as 
the mean glucose difference was near zero (- 0.056 mmol / 
L, p = 0.3128). The regression line indicated that the mean 
glucose differences between methods (y line) did not have 
a homogeneous or consistent distribution over the range of 
glucose averages used in group 4 (β = - 0.052, p = 0.0193); 
in other words, as the glucose average increases (x line), the 
glucose levels measured by the HC were lower than those 
measured by the GOx. The limits of agreement were - 1.599 
(- 2SD) to 1.488 (2SD) with 7.61 % of differences or errors 
outside the limits of concordance.
Finally, for Group 5, a lack of concordance was found 
between the methods (Figure 5), since the mean of glucose 
differences was less than zero (- 0.173 mmol / L, p = 0.0350). In 
this case, the regression line showed that the mean differenc-
 
 Figure 2. Mean difference for glucose measurements between HemoCue 
and Glucose oxidase method (reference method) versus their glucose 
average, for people with glucose values < 5.55 mmol / L.
Figura 2. Diferencia de media vs promedio de glucosa (mmol / L) entre los 
métodos HemoCue y glucosa oxidasa (método de referencia) para personas 
con valores de glucosa < 5.55 mmol / L.
 
 Figure 3. Mean difference for glucose measurements between HemoCue 
and Glucose oxidase method (reference method) versus their glucose 
average, for people with glucose values < 6.993 mmol / L. 
Figura 3. Diferencia de media vs promedios de glucosa (mmol / L) entre los 
métodos Hemocue y glucosa oxidasa (método de referencia) para personas 




Figure 4. Mean difference for glucose measurements between HemoCue 
and Glucose oxidase method (reference method) versus their glucose 
average, for people with glucose values ≥ 5.55 mmol / L.
Figura 4. Diferencia de media vs promedio de glucosa (mmol / L) entre los 
métodos HemoCue y glucosa oxidasa (método de referencia) para personas 
con niveles de glucosa ≥ 5.55 mmol / L.
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es were homogeneously distributed (β = - 0.05, p = 0.1034) in 
the range of high glucose levels (≥ 6.993 mmol / L). In other 
words, the glucose levels measured by the HC were lower 
than those measured by the GOx at for all values included in 
Group 5. The limits of agreement were - 1.613 (- 2SD) to 1.267 
(2SD) and that 7.5% of differences or errors were outside the 
limits of concordance.
It is important to take into account that in the present 
study, glucose measurements were performed on different 
specimens (venous total blood and plasma) and also relied 
on different mechanisms. For instance, the GOx method is 
based on the enzymatic oxidation of glucose in the pres-
ence of the enzyme glucose oxidase and the HC is based in 
a modified technique of glucose dehydrogenase using the 
saponification of erythrocytes.
Several studies have made comparisons of blood glu-
cose levels measured with different glucometers in different 
types of glucose samples and with different types of methods. 
Some of these studies were focused on the clinic practice, 
while others focused on hospitalized patients, newborns, or 
diabetic patients self-monitoring their glucose. However, few 
studies have been focused on the HC as a method to measure 
glucose in the fieldwork as part of a research study (Dohnal et 
al., 2010; Ignell y Berntorp, 2011; Warner et al., 2011; Pfützner 
et al., 2012; Salacinski et al., 2014; Sudha et al., 2014;).
Sudha and collaborators in 2014 compared the HC 
201 system, the B Braun glucometer, and the GOx technique 
used in a reference clinical laboratory. Patients were neo-
nates from the Neonatal Intensive Care Unit. Glucose was 
measured in capillary and venous whole blood with the two 
glucometers and in plasma samples using the GOx technique 
in the reference clinical laboratory. The result showed that 
glucose levels  measured by the B Braun glucometer were sig-
nificantly higher than those measured in plasma by the GOx 
technique  (5.561 ± 2.686 mmol / L vs 4.271 ± 2.552 mmol / L, 
p = 0.003) and those measured by HC (5.561 ± 2.686 mmol / 
L vs 4.60 ± 2.853 mmol / L). On the contrary, a non-significant 
difference was found between the glucose  measured by the 
HC and that obtained by the GOx method  (4.60 ± 2.853 mmol 
/ L vs vs 4.271 ± 2.552 mmol / L), even in the lowest glucose 
range (< 3.0525 mmol / L) (p = 0.463). The authors concluded 
that the HC was a device suitable for glucose analysis in the 
neonatal care unit, since the results obtained showed an 
excellent correlation with those obtained by the GOx in the 
laboratory (Sudha et al., 2014).
Similarly, in the present study, a non-significant differ-
ence was found when comparing the glucose  measured by 
the HC and the GOx methods when all glucose values were 
analyzed as well as when glucose measurements were lower 
than 6.993 mmol / L (Figure 1 to 4). 
In a study carried out in 2005 by Stork et al., in hos-
pitalized diabetic patients, glucose values  analyzed by HC 
and the Yellow Springs Instrument glucose analyzer (YSI), 
which uses the GOx technique, where compared. Glucose 
values measured with the HC system was highly correlated 
with those measured by the YSI analyzer in a wide range of 
glucose concentrations, which led the authors to conclude 
that both methods can be used interchangeably for clinical 
and research purposes in the studied adult population.
Our results resemble those found by Stork et al., in 
2005. As in our work, they found a close relationship be-
tween HC and the reference method used in normal glucose 
concentration ranges. However, they also noticed that HC 
overestimates glucose values  at concentrations greater than 
11.0445 mmol / L, while in the present study it was found that 
at glucose values  above 6.993 mmol / L, HC underestimated 
the glucose concentration.
When analyzing the differences between the group 
methods, it was observed that most of the differences (errors 
or biases) were within ± 2SD (Group 1 = 94.74 %, Group 2 
= 92.4 %, Group 3 = 94.8 %, Group 4 = 94.8 % and Group 
5 = 94.3 %). Stork and collaborators and Torjman and col-
laborators showed that 97 % and 95 % of their differences 
were within the limits of agreement (± 2SD), which was very 
similar to what was found in our study (Torjman et al., 2001; 
Stork et al., 2005).
Several studies have measured the accuracy of HC 
when compared to other routinely used methods in labora-
tories and to different types of glucometers with contradicto-
ry findings. While some conclude that the HC is an effective 
device for measuring blood glucose (Bellini et al., 2007; 
Leonard et al., 1997), some conclude that HC overestimates 
glucose levels (Stork et al., 2005), and others conclude that 
HC underestimates glucose levels (Torjman et al., 2001). In 
the opinion of some of these authors, the results could be 
influenced by external factors that played an important role 
in these variations and even by the concentrations of glucose 
 
 
 Figure 5. Mean difference for glucose measurements between HemoCue 
and Glucose oxidase method (reference method) versus their glucose 
average, for people with glucose values ≥ 6.993 mmol / L.
Figura 5. Diferencia de media vs promedio de glucosa (mmol / L) entre los 
métodos HemoCue y glucosa oxidasa (método de referencia) para personas 
con niveles de glucosa ≥ 6.993 mmol / L.
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(Torjman et al., 2001; Stork et al., 2005; Leonard et al., 1997). 
In the present work, and with the understanding that there 
were no duplicates of the measurements made in HC, special 
care was taken in the handling of the samples, both in the 
HC equipment as well as with its microcuvettes, in order 
to minimize the influence of external factors. With the GOx 
technique duplicate samples were taken, and the coefficient 
of variation (CV) for total plasma glucose values was 1.19 %, 
< 5.55 mmol / L values CV: 1.12 %; > 5.55 mmol / L values CV: 
1.24 %; < 6.993 mmol / L values CV: 1.17 % and > 6.993 mmol 
/ L values CV: 1.25 %. 
For studies measuring blood glucose it is important 
to consider the accuracy and variability of the reference 
method used, since the gold standard, isotopic dilution mass 
spectrometry, is very expensive and therefore difficult to ac-
cess in any laboratory. Therefore, a discrepancy between two 
paired measurements of two different devices or techniques 
does not necessarily imply that the tested method is not as 
accurate as the reference method used; rather, more research 
is needed on the performance validation of these portable 
instruments, especially if values are used interchangeably 
between whole blood and plasma (Rebel et al., 2012).
CONCLUSIONS
These results showed concordance between the HC 
and GOx methods, mainly at glucose levels less than 6.993 
mmol / L. The HC glucose analyzer was good for use in re-
search studies since it is technically easy and requires very 
little maintenance; however, it is recommended that special 
care be taken with those people with borderline glucose 
values, or those within the limits of diabetes diagnosis, since 
there is a risk of misclassifying persons that already have 
diabetes as not having diabetes when using the HC method. 
Thus, given the importance of knowing the real values  of glu-
cose levels in this group of people for an accurate diagnosis, 
it is recommended to consider a subsequent analysis with 
the GOx method to corroborate the result.
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